Insider trade

Officer sold ~$911K of ELV shares in the open market

Traded Mar 6, 2026 · Filed Mar 9, 2026

Elevance HealthELV

~$911K
Reported value · 3,196 sh @ $284.92: 12K
Holds after · shares reported: +31.8%
stock since the trade · S&P 500 +13.6%, $289.64 → $381.67 on Oct 1

Why it stands out

Elevance Health's & President, Commercial sold $911K of Elevance Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 6, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 9, 2026

Officer$500K–$1M

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$910,604

Shares × reported transaction price

Timing vs results

37 days after results of Jan 28, 2026, 47 days before results of Apr 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $289.64 on Mar 6, 2026, 5% above its 52-week low and 36% below its high, after a 22% drop over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $452.69 (Apr 3, 2025), 8% of the way up, from 251 adjusted closes. 30 trading days earlier: $372.24 on Jan 22, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	+4.6%	-0.9%	+5.6%
30 days	+12.1%	+0.4%	+11.7%
90 days	+47.9%	+9.2%	+38.8%
180 days	+42.2%	+13.1%	+29.1%

Past results only. Not a forecast.

Source receipt

Record ID: 0001887908-26-000005
Filed / recorded: Mar 9, 2026, 8:45 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: Elevance Health, Inc.
Issuer CIK: 1156039
Ticker: ELV
Reporting person: Charles Morgan Jr Kendrick
Relationship: Officer
Officer title: EVP & President, Commercial
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Mar 6, 2026
Transaction code: S
Shares / units: 3,196
Price per share: $284.92
Acquired / disposed: Disposed (D)
Shares owned after: 11,791
Ownership form: Direct
Amendment: No

Footnotes from the filing

This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Around the same time

Director sold7mo ago

~$7.5KReported value · 26 sh @ $287.50

A board member of Elevance Health sold $7.5K of Elevance Health shares. Nobody planned it ahead of time.

Why it stands out Official record

Director bought7mo ago

~$870KReported value · 3,000 sh @ $289.84

A board member of Elevance Health spent $870K of their very own money to buy Elevance Health shares. Their pile of Elevance Health shares grew by 470%.

Why it stands out Official record

7mo ago

131Shares · @ $294.07

Routine share withholding; mechanical by default.

Why it stands out Official record